Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Vestn Ross Akad Med Nauk ; (5): 14-6, 2005.
Artigo em Russo | MEDLINE | ID: mdl-15960197

RESUMO

The authors examined 25 patients with prostate cancer (PC) and 36 patients with benign prostatic hyperplasia (BPH). In the group of patients with morphologically verified PC mean serum level of vascular endothelial growth factor (VEGF) was significantly higher than in patients with BPH (p < 0.05). The study demonstrated strong negative association between VEGF and prostate specific antigen (PSA) levels (r = 0.72, p < 0.05) in PC patients. There was no association between VEGF serum level and the stage or malignancy of PC (Gleason score). In benign prostatic glands moderate VEGF expression was observed only in basal cells, whereas in cases of PC all tumor cells displayed active VEGF expression; the difference was significant (p < 0.05). High serum VEGF levels and its active expression in patients with PC suggest an important role of angiogenic factors in the pathogenesis of this disease. The negative association between VEGF and PSA serum levels in PC indirectly confirms antiangiogenic activity of PSA, shown before.


Assuntos
Hiperplasia Prostática/sangue , Neoplasias da Próstata/sangue , Fator A de Crescimento do Endotélio Vascular/sangue , Idoso , Biomarcadores/sangue , Biópsia , Humanos , Imuno-Histoquímica , Masculino , Estadiamento de Neoplasias , Neovascularização Patológica/sangue , Neovascularização Patológica/patologia , Antígeno Prostático Específico/sangue , Hiperplasia Prostática/patologia , Neoplasias da Próstata/irrigação sanguínea , Neoplasias da Próstata/patologia , Índice de Gravidade de Doença , Fator A de Crescimento do Endotélio Vascular/biossíntese
2.
FEBS Lett ; 579(14): 3147-51, 2005 Jun 06.
Artigo em Inglês | MEDLINE | ID: mdl-15919078

RESUMO

Sensory rhodopsin II (SRII) from Halobacterium salinarum is heterologously expressed in Escherichia coli with a yield of 3-4 mg of purified SRII per liter cell culture. UV/Vis absorption spectroscopy display bands characteristic for native SRII. The resonance Raman spectrum provides evidence for a strongly hydrogen-bonded Schiff base like in mammalian rhodopsin but unlike to the homologous pSRII from Natronobacterium pharaonis. Laser flash spectroscopy indicates that SRII in detergent as well as after reconstitution into polar lipids shows its typical photochemical properties with prolonged photocycle kinetics. The first functional heterologous expression of SRII from H. salinarum provides the basis for studies with its cognate transducer HtrII to investigate the molecular processes involved in phototransduction as well as in chemotransduction.


Assuntos
Escherichia coli/genética , Halobacterium salinarum/genética , Rodopsinas Sensoriais/genética , Rodopsinas Sensoriais/metabolismo , Eletroforese , Cinética , Proteínas Recombinantes/genética , Proteínas Recombinantes/isolamento & purificação , Proteínas Recombinantes/metabolismo , Rodopsinas Sensoriais/isolamento & purificação , Análise Espectral Raman
3.
Urologiia ; (1): 17-21, 2004.
Artigo em Russo | MEDLINE | ID: mdl-15022438

RESUMO

To study the levels of vascular endothelium growth factor (VEGF), insulin-like growth factor of type I and II (IGF-I and IGF-II), prostate-specific antigen (PSA) and their correlations in prostatic cancer (PC) and benign prostatic hyperplasia (BPH), we examined 38 PC patients (mean age 66.6 +/- 5.5 years) and 80 BPH patients (mean age 60.3 +/- 2.5 years). Serum concentrations of VEGF, IGF-I and IGF-II were measured using kits made by R&D (USA), PSA by Boehringer Mannheim (Germany). Sensitivity and specificity of the tests were analysed by plotting the curves. The serum VEGF concentration in PC patients was 518.9 +/- 60.7 pkg/ml, in BPH patients--267.9 +/- 99.9 pkg/ml (p < 0.001). The IGF-I and IGF-II it was 178 +/- 19 and 136 +/- 9 ng/ml (p < 0.05), 400 +/- 31 and 351 +/- 23 ng/ml (p < 0.05), respectively. The ratio of growth factor concentration to PSA concentration in the blood serum in BPH patients was higher than in PC patients (p < 0.01). Sensitivity and specificity of PSA (4 ng/ml) made up 85.7 and 57%, VEGF (151.5 pg/ml)--76.2 and 57.6%, IGF-I (157 ng/ml)--57.6 and 50%; IGF-II (392 ng/ml)--57.5 and 50%, respectively. Sensitivity and specificity VEGF/PSA was 85.7 and 70%; IGF-I/PSA--84.2 and 75%; IGF-II/PSA--84.2 and 79.6%, respectively. Thus, the ratio of concentrations of IGF-I, IGF-II and VEGF to PSA level in blood serum has high sensitivity and specificity for PC detection. Clinical implications of serum levels of VEGF, IGF-I and IGF-II for prediction of PC course and detection is to be elicited.


Assuntos
Fator de Crescimento Insulin-Like II/análise , Fator de Crescimento Insulin-Like I/análise , Hiperplasia Prostática/diagnóstico , Neoplasias da Próstata/diagnóstico , Fator A de Crescimento do Endotélio Vascular/sangue , Adenocarcinoma/diagnóstico , Adenocarcinoma/metabolismo , Idoso , Biomarcadores Tumorais/sangue , Diagnóstico Diferencial , Humanos , Masculino , Pessoa de Meia-Idade , Estadiamento de Neoplasias , Hiperplasia Prostática/metabolismo , Hiperplasia Prostática/patologia , Neoplasias da Próstata/metabolismo , Neoplasias da Próstata/patologia
4.
Klin Med (Mosk) ; 81(2): 54-7, 2003.
Artigo em Russo | MEDLINE | ID: mdl-12685238

RESUMO

The efficacy of monotherapy with one of the analogues of synthetic nucleosides (lamivudine) was studied in 22 patients with chronic viral hepatitis B (CVHB). The specific feature of the selected group was that there was no serum HBeAg, which is usually regarded as a sign of viral mutation. The time course of changes in the activity of blood and hepatic inflammatory processes and viral replication were studied at equal intervals. There was a direct correlation between the suppression of viral replication and the regression of activity indices, such as ALT, serological markers, DNA of viral hepatitis B, and the morphological constituents of the Knodell index) during lamivudine therapy. However, there were no substantial changes in the parameters of fibrosis throughout the treatment. Therapy resistance was revealed in 3 of the 22 patients with CVHV. Its basis was the mutation of hepatitis B virus in the YMDD-motive, which was detected in 2 of the 3 patients.


Assuntos
Antivirais/administração & dosagem , Vírus da Hepatite B/isolamento & purificação , Hepatite B Crônica/tratamento farmacológico , Lamivudina/administração & dosagem , Adulto , Idoso , Antivirais/farmacologia , DNA Viral/isolamento & purificação , Esquema de Medicação , Farmacorresistência Viral , Feminino , Antígenos E da Hepatite B/sangue , Vírus da Hepatite B/efeitos dos fármacos , Vírus da Hepatite B/genética , Vírus da Hepatite B/imunologia , Hepatite B Crônica/imunologia , Hepatite B Crônica/patologia , Humanos , Lamivudina/farmacologia , Masculino , Pessoa de Meia-Idade , Mutação , Resultado do Tratamento
6.
Vestn Akad Med Nauk SSSR ; (5): 3-7, 1991.
Artigo em Russo | MEDLINE | ID: mdl-1866998

RESUMO

The paper provides strong evidence for further postmortem investigations in the ante- and perinatal periods, in the combination of those of the afterbirth. The very early antenatal abnormalities (gametopathy and blastopathy) have been less studied. There are predominant congenital malformations of the organs concurrent with placental incompetence among embryopathies. In the fetal period, the authors identify an abnormality in the early fetal phase when placental insufficiency, fetal hypoxia and intrauterine death prevail; that in the mid fetal phase concomitant with infectious fetal injuries and acute and chronic placental failures due to maternal diseases; and that in the late fetal phase that covers perinatal death. The time course of reasons for stillbirth and neonatal death was analyzed in Moscow in 1986-1989. Etiological causes of early and late abortions have been identified, which is a real reserve of reduction in ante- and perinatal mortality rates in this country.


Assuntos
Aborto Espontâneo/etiologia , Anormalidades Congênitas/etiologia , Doenças Fetais/etiologia , Insuficiência Placentária/complicações , Feminino , Humanos , Gravidez
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...